A risk-benefit assessment of abciximab in angioplastyKLEIMAN, N. S.Drug safety. 1999, Vol 20, Num 1, pp 43-57, issn 0114-5916Article

DNA single strand breaks in human lens epithelial cells from patients with cataractKLEIMAN, N. J; SPECTOR, A.Current eye research (Print). 1993, Vol 12, Num 5, pp 423-431, issn 0271-3683Article

ANTICOAGULANT THERAPY IN ACUTE MYOCARDIAL INFARCTION: DEMONSTRATION OF A SELECTION BIAS IN A RETROSPECTIVE STUDYRAVID M; KLEIMAN N; SHAPIRA J et al.1980; THROMB. RES.; ISSN 0049-3848; USA; DA. 1980; VOL. 18; NO 6; PP. 753-756; BIBL. 13 REF.Article

Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting : results from a multicentre randomised trialTOPOL, E. J; MARK, D. B; ANDERSON, K. M et al.Lancet (British edition). 1999, Vol 354, Num 9195, pp 2019-2024, issn 0140-6736Article

Detection of transplant arteriopathy : does exercise thallium scintigraphy improve noninvasive diagnostic capabilities ?SMART, F. W; GRINSTEAD, W. C; COCANOUGHER, B et al.Transplantation proceedings. 1991, Vol 23, Num 1, pp 1189-1192, issn 0041-1345, 2Conference Paper

Heparin-induced prolongation of partial thrombooplastin time after thrombolysis : relation to coronary artery patencyHSIA, J; KLEIMAN, N; AGUIRRE, F et al.Journal of the American College of Cardiology. 1992, Vol 20, Num 1, pp 31-35, issn 0735-1097Article

Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deploymentKEREIAKES, D. J; KLEIMAN, N; FERGUSON, J. J et al.Circulation (New York, N.Y.). 1997, Vol 96, Num 4, pp 1117-1121, issn 0009-7322Article

A comparison between Heparin and low-dose Aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarctionHSIA, J; HAMILTON, W. P; KLEIMAN, N et al.The New England journal of medicine. 1990, Vol 323, Num 21, pp 1433-1437, issn 0028-4793Article

Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction : The TIMI III registrySTONE, P. H; THOMPSON, B; KELLS, C et al.JAMA, the journal of the American Medical Association. 1996, Vol 275, Num 14, pp 1104-1112, issn 0098-7484Article

Relation of left ventricular dilation during acute myocardial infarction to systolic performance, diastolic dysfunction, infarct size and locationSEALS, A. A; PRATT, C. M; MAHMARIAN, J. J et al.The American journal of cardiology. 1988, Vol 61, Num 4, pp 224-229, issn 0002-9149Article

Lack of usefulness of prolonged bleeding times in predicting hemorrhagic events in patients receiving the 7E3 glycoprotein IIb/IIIa platelet antibodyBERNARDI, M. M; CALIFF, R. M; KLEIMAN, N et al.The American journal of cardiology. 1993, Vol 72, Num 15, pp 1121-1125, issn 0002-9149Article

Confronting the issues of patient safety and investigator conflict of interest in an international clinical trial of myocardial reperfusionTOPOL, E. J; ARMSTRONG, P; VAN DE WERF, F et al.Journal of the American College of Cardiology. 1992, Vol 19, Num 6, pp 1123-1128, issn 0735-1097Article

Description of patients undergoing high risk angioplasty : analyses of various databasesKLEIMAN, N. S.European heart journal. 1995, Vol 16, Num NOV, pp 30-35, issn 0195-668X, SUPLConference Paper

Goals of thrombolytic therapyKLEIMAN, N. S.The American journal of cardiology. 1991, Vol 68, Num 12, pp 67C-71C, issn 0002-9149Article

Hydrogen peroxide-induced DNA damage in bovine lens epithelial cellsKLEIMAN, N. J; WANG, R. R; SPECTOR, A et al.Mutation research. 1990, Vol 240, Num 1, pp 35-45, issn 0027-5107Article

Pharmacokinetics and pharmacodynamics of glycoprotein IIb-IIIa inhibitorsKLEIMAN, N. S.The American heart journal. 1999, Vol 138, Num 4, pp S263-S275, issn 0002-8703, 2Conference Paper

Primary and secondary safety endpoints from IMPACT IIKLEIMAN, N. S.The American journal of cardiology. 1997, Vol 80, Num 4A, pp 29B-33B, issn 0002-9149Conference Paper

Ultraviolet light induced DNA damage and repair in bovine lens epithelial cellsKLEIMAN, N. J; WANG, R.-R; SPECTOR, A et al.Current eye research (Print). 1990, Vol 9, Num 12, pp 1185-1193, issn 0271-3683, 9 p.Article

Percutaneous transluminal coronary angioplasty : is what we see what we get ?KLEIMAN, N. S; RAIZNER, A. E; ROBERRTS, R et al.Journal of the American College of Cardiology. 1990, Vol 16, Num 3, pp 576-577, issn 0735-1097, 2 p.Article

Safety issues surrounding use of platelet GP IIb/IIIa antagonists : reversibility and readministrationKLEIMAN, N. S; TCHENG, J. E.European heart journal supplements. 1999, Vol 1, Num E, pp E36-E42, issn 1520-765XConference Paper

Nuclear protein phosphorylation in isolated nuclei from HeLa cells. Evidence that ³²P incorporation from [γ-³²P] GTP is catalyzed by nuclear kinase IIFRIEDMAN, D. L; KLEIMAN, N. J; CAMPBELL, F. E. JR et al.Biochimica et biophysica acta. 1985, Vol 847, Num 2, pp 165-176, issn 0006-3002Article

Platelet glycoprotein IIb/IIIa antagonists : What are the relevant issues concerning their pharmacology and clinical use?SCARBOROUGH, R. M; KLEIMAN, N. S; PHILLIPS, D. R et al.Circulation (New York, N.Y.). 1999, Vol 100, Num 4, pp 437-444, issn 0009-7322Article

Interobserver variability in grading of coronary arterial narrowings using the American college of cardiology/American heart association grading criteriaKLEIMAN, N. S; RODRIGUEZ, A. R; RAIZNER, A. E et al.The American journal of cardiology. 1992, Vol 69, Num 4, pp 413-415, issn 0002-9149Article

Microperoxidases catalytically degrade reactive oxygen species and may be anti-cataract agentsSPECTOR, A; MA, W; WANG, R.-R et al.Experimental eye research. 1997, Vol 65, Num 4, pp 457-470, issn 0014-4835Article

Development and characterization of an H₂O₂-Resistant immortal lens epithelial cell lineSPECTOR, A; WANG, R.-R; WANCHAO MA et al.Investigative ophthalmology & visual science. 2000, Vol 41, Num 3, pp 832-843, issn 0146-0404Article